Esophageal Variceal Bleeding
📧 Sign up to get email alerts when something new happens for Esophageal Variceal Bleeding.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: TEAS for Variceal Bleeding Endoscopy in Cirrhosis [NA]
A completed clinical trial evaluating TEAS for variceal bleeding management during endoscopy in patients with cirrhosis.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis. [NA]
This clinical trial from The Chinese University of Hong Kong is evaluating whether EUS-guided portal-systemic pressure gradient measurement …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: EUS Glue vs Endoscopic Variceal Band Ligation for Prevention of Rebleeding in Patients With HCC and EV Bleeding: a Retrospective Comparative Study
A retrospective comparative study evaluating EUS-guided cyanoacrylate injection versus endoscopic variceal band ligation for preventing rebl…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients [NA]
A clinical trial comparing endoscopic ultrasound-guided therapy with conventional endoscopic therapy to prevent variceal rebleeding in patie…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Construction of a Portal Hypertension Biobank
A clinical trial to construct a portal hypertension biobank; recruiting participants with portal hypertension or variceal bleeding.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)
Clinical trial evaluating 6-10 mm diameter VIATORR TIPS stent grafts in patients with ascites and variceal bleeding due to portal hypertensi…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices [Phase 4]
Phase 4 clinical trial comparing carvedilol to propranolol to prevent rebleeding after endoscopic treatment of cirrhotic varices in patients…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Underdilated-stent Technique Improves Post-TIPS Encephalopathy [NA]
A clinical trial update shows recruitment for a study evaluating an underdilated-stent technique to improve post-TIPS hepatic encephalopathy…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension [NA]
Clinical trial update describing a study evaluating the effectiveness and safety of a TIPS stent graft for portal hypertension due to cirrho…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis [NA]
A clinical trial is comparing underdilated versus standard transjugular intrahepatic portosystemic shunt (TIPS) to prevent variceal rebleedi…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices [Phase 4]
Phase 4 trial comparing 24-hour versus 72-hour octreotide infusion to prevent early rebleeding from esophageal varices in patients with live…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Effectiveness of Treatments for Cirrhosis With Varicose Veins
The document provides an update on the effectiveness of treatments for cirrhosis with varicose veins, focusing on esophageal variceal bleedi…
-
CLINICAL_TRIALS other · 2025-02-27Clinical Trial Update: Timing of Endoscopy in Cirrhotic Patients with Acute Variceal Bleeding [NA]
A study evaluating when to perform endoscopy in cirrhotic patients with acute variceal bleeding is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Efficacy and Safety of Intravenous Vitamin K1 in Management of Acute Variceal Bleeding [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of intravenous vitamin K1 for management of acute variceal bleeding.
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal Bleed [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing continuous infusion of terlipressin versus bolus terlipressin in patients with acute on chronic liver f…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma [NA]
The document reports on an ongoing study evaluating early transjugular intrahepatic portosystemic shunt (TIPS) for advanced hepatocellular c…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
This study is evaluating whether the albumin–bilirubin index can predict outcomes in patients with variceal bleeding; recruitment is ongoing…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer [Phase 3]
Phase 3 trial update evaluating vonoprazan for preventing ulcers after variceal band ligation in patients with portal hypertension and varic…
-
FDA approval · 2024-07-09FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for octreotide acetate (ANDA 203765) submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceut…
-
FDA approval · 2024-02-09FDA Approved: VASOPRESSIN — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for a generic vasopressin product from Sagent Pharmaceuticals.
-
FDA approval · 2023-06-30FDA Approved: OCTREOTIDE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for octreotide acetate filed by Fresenius Kabi USA, LLC.
-
FDA approval · 2023-06-22FDA Approved: OCTREOTIDE ACETATE — Original Application (Gland Pharma Limited)
FDA approved OCTREOTIDE ACETATE from Gland Pharma Limited via an Original Application (ANDA 216839), establishing a generic version of octre…
-
FDA approval · 2023-06-13FDA Approved: OCTREOTIDE ACETATE — Original Application (Gland Pharma Limited)
FDA approved the original application for octreotide acetate, a generic product from Gland Pharma Limited. Octreotide acetate is indicated f…
-
FDA approval · 2023-02-21FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for octreotide acetate by Mylan Institutional LLC under ANDA 079198, granting a supplemental approva…
-
FDA approval · 2023-02-21FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application to Heritage Pharmaceuticals (Avet) for octreotide acetate, a generic product, under an ANDA.